Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 359

1.
2.

Two "knockout" mouse models demonstrate that aortic vasodilatation is mediated via alpha2a-adrenoceptors located on the endothelium.

Shafaroudi MM, McBride M, Deighan C, Wokoma A, Macmillan J, Daly CJ, McGrath JC.

J Pharmacol Exp Ther. 2005 Aug;314(2):804-10. Epub 2005 May 5.

4.

Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.

Bexis S, Vandeputte C, McCormick PA, Docherty JR.

Eur J Pharmacol. 2004 Sep 24;499(3):325-33.

PMID:
15381055
5.

Role of the endothelium on the response to adrenoceptor agonists of rabbit aorta during cooling.

Atalik EK, Sahin AS, Kiliç M, Doğan N.

Fundam Clin Pharmacol. 2000 Jan-Feb;14(1):25-30.

PMID:
10681071
6.

Investigation of neurotransmission in vas deferens from alpha(2A/D)-adrenoceptor knockout mice.

Cleary L, Vandeputte C, Docherty JR.

Br J Pharmacol. 2002 Jul;136(6):857-64.

7.

Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.

Rajamani K, Leong S, Lavelle A, Docherty JR.

Eur J Pharmacol. 2001 Jul 6;423(2-3):223-8.

PMID:
11448488
8.
9.

Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2.

Qu C, Leung SW, Vanhoutte PM, Man RY.

J Pharmacol Exp Ther. 2010 Aug;334(2):373-80. doi: 10.1124/jpet.110.167098. Epub 2010 May 5.

10.

Vascular actions of 3,4-methylenedioxymethamphetamine in alpha(2A/D)-adrenoceptor knockout mice.

Vandeputte C, Docherty JR.

Eur J Pharmacol. 2002 Dec 13;457(1):45-9.

PMID:
12460642
11.

Combined lack of estrogen receptors alpha and beta affects vascular iNOS protein expression.

Liang M, Ekblad E, Lydrup ML, Nilsson BO.

Cell Tissue Res. 2003 Jul;313(1):63-70. Epub 2003 Jun 24.

PMID:
12827494
12.

Phenylephrine induces endogenous noradrenaline release in the rat vas deferens through nitric oxide synthase pathway.

Pinto R, Barrento C, Mota-Filipe H, Lima BS.

Pharmacol Toxicol. 2003 Oct;93(4):191-6.

PMID:
14629744
14.

Modulation by NO of acetylcholine release in the ileum of wild-type and NOS gene knockout mice.

Mang CF, Truempler S, Erbelding D, Kilbinger H.

Am J Physiol Gastrointest Liver Physiol. 2002 Nov;283(5):G1132-8.

PMID:
12381527
15.

Alpha 1-adrenoceptor vasoconstriction in the tail artery during ageing.

Vila E, Vivas NM, Tabernero A, Giraldo J, Arribas SM.

Br J Pharmacol. 1997 Jul;121(5):1017-23.

16.

Neuronal nitric oxide synthase-derived hydrogen peroxide is a major endothelium-dependent relaxing factor.

Capettini LS, Cortes SF, Gomes MA, Silva GA, Pesquero JL, Lopes MJ, Teixeira MM, Lemos VS.

Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2503-11. doi: 10.1152/ajpheart.00731.2008. Epub 2008 Oct 24.

PMID:
18952716
17.

Nitric oxide synthase-independent release of nitric oxide induced by KCl in the perfused mesenteric bed of the rat.

Mendizabal VE, Poblete I, Lomniczi A, Rettori V, Huidobro-Toro JP, Adler-Graschinsky E.

Eur J Pharmacol. 2000 Dec 1;409(1):85-91.

PMID:
11099704
19.

Alpha-vascular responses after short-term and long-term inhibition of nitric oxide synthesis.

Aleixandre A, López-Miranda V, Ortega A.

J Cardiovasc Pharmacol. 2001 Feb;37(2):133-42.

PMID:
11209996
20.

Endothelial inhibitory modulation on the contractile responses to alpha 2-adrenergic agonists.

Gil-Gastelum O, Valencia I, Larios FJ, Castillo EF, Castillo C.

Proc West Pharmacol Soc. 2002;45:88-9. No abstract available.

PMID:
12434540

Supplemental Content

Support Center